7/13/2009

The FDA approved prasugrel, an anti-clotting drug from Daiichi Sankyo and Eli Lilly. The product will be launched under the brand name Effient and carry a black-box warning about an increased risk of potentially fatal bleeding.

Full Story:
Bloomberg

Related Summaries